Arthritis Gouty

• EMA approval · 2026-08-19
  EMA Authorised: Febuxostat Viatris (previously Febuxostat Mylan) (febuxostat) — Viatris Limited

  European Medicines Agency authorised Febuxostat Viatris for hyperuricemia and gout-related indications.

• CLINICAL_TRIALS trial_result · 2023-05-12
  Clinical Trial Update: Phase 2b Evaluation of Efficacy and Safety of AR882 in Gout Patients [Phase 2]

  Phase 2b trial evaluating AR882 for gout shows completed status; provides data on efficacy and safety in gout patients.